PATENT CLAIM ANALYSIS

Application Number: 15742422
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "129000"]

Abstract:
Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 8  are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

Claim (Index 19):
The compound of  claim 1 , wherein R 4  is \u2014P(O)(R a ) 2 , \u2014S(O) x R b , \u2014C(O)R c , \u2014C(O)OR c , \u2014C(O)N(R d ) 2 , \u2014(CH 2 ) x C(O)N(R d ) 2 , \u2014(CH 2 ) n OP(O)(R a ) 2 , \u2014(CH 2 ) m OS(O) x R b , \u2014(CH 2 ) p OC(O)R c , or \u2014(CH 2 ) p C(O)OR c ;\n R 5  is hydrogen; each of R a  and R b  is independently selected from \u2014OR d  or alkyl; each R c  is independently alkyl (e.g., \u2014CH 2 NH 2 , \u2014CH 2 CH 2 CO 2 H, \u2014CH(CH(CH 3 ) 2 )NH 2 , \u2014CH 2 CH 2 C(O)OH, or \u2014CH(CH 3 )NH 2 ); each R d  is independently hydrogen or alkyl; each x is independently 1 or 2; and each of n, m, p is independently 1, 2, 3, or 4.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15552201', '15660114', '15312614', '13993198', '15314599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7808262746664241
- 35 USC 102 Novelty (BERT): 0.5539936247926962
- Combined Prediction Score: 0.7581430096790512
- Mean Citation Score: 344.124902
- Max Citation Score: 358.68613
- Similarity Product: 224.4971271522188

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test